Jump to main content
Jump to site search

Issue 68, 2017
Previous Article Next Article

Potentiating the immune response of MUC1-based antitumor vaccines using a peptide-based nanovector as a promising vaccine adjuvant

Author affiliations

Abstract

We utilize the supramolecular self-assembling peptide of Nap-GDFDFDYDK to construct chemically programmed, self-assembling and self-adjuvant MUC1-based antitumor vaccines. The vaccines, with antigen and adjuvant conjugation through covalent bonds, elicited both humoral and cellular immune responses.

Graphical abstract: Potentiating the immune response of MUC1-based antitumor vaccines using a peptide-based nanovector as a promising vaccine adjuvant

Back to tab navigation

Supplementary files

Publication details

The article was received on 06 Jun 2017, accepted on 01 Aug 2017 and first published on 01 Aug 2017


Article type: Communication
DOI: 10.1039/C7CC04386D
Citation: Chem. Commun., 2017,53, 9486-9489
  •   Request permissions

    Potentiating the immune response of MUC1-based antitumor vaccines using a peptide-based nanovector as a promising vaccine adjuvant

    Y. Liu, Y. Wang, F. Yu, Z. Zhang, Z. Yang, W. Zhang, P. G. Wang and W. Zhao, Chem. Commun., 2017, 53, 9486
    DOI: 10.1039/C7CC04386D

Search articles by author

Spotlight

Advertisements